Quality of Life, Decision-making, Resilience, Satisfaction and Success Rate of Different IVF Treatment Strategies: an International Prospective Cohort Study
Study aims to assess the quality of life and mental health of patients suffering from infertility. Secondly, this study aims to discover the true reasons for choosing a certain IVF treatment (whether quality of life related or otherwise) and the extent to which defined factors (e.g. cost, doctor recommendations, stress levels and effectiveness) influence this choice. Thirdly, the study aims to examine psychological resilience in adhering to a treatment choice and the reasons for changing treatment. Finally, we will evaluate the cumulative live birth rate over a planned timeframe, including that experienced with IVF Naturelle, as these are currently unknown.
Studieoversikt
Status
Status
Forhold
Forhold
Studietype
Studietype
Registrering (Antatt)
Registrering
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Michael von Wolff, Professor
- Telefonnummer: 0041 31 632 13 01
- E-post: michael.vonwolff@insel.ch
Studiesteder
-
-
Canton of Bern
-
Bern, Canton of Bern, Sveits, 3000
- Rekruttering
- Frauenklinik Bern, Universitätspital Inselspital Bern
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The project population consists IVF patients who are willing to participate in this study. Patients should not have had an IVF treatment before or, if a clinical pregnancy had been achieved by IVF, a new IVF therapy should not have started since then.
After receiving advice on the advantages and disadvantages of each type of in vitro fertilisation treatment (NC/ Min-stim IVF and cIVF strategy), couples will be free to decide which IVF treatment strategy they wish to follow. Couple are also free to change treatment strategy during the 6 month treatment phase.
Beskrivelse
Inclusion Criteria:
- Female patient age ≥ 18 till 44
- Indication for IVF/ICSI
- First IVF treatment or first IVF treatment after a clinical pregnancy (spontaneous conception or pregnancy achieved by IVF)
- Cycles with intended fresh and/or frozen ETs within 6 months (= study period)
- In case of NC-IVF: regular menstrual cycle (Eumenorrhae = 24-38 day of cycle)
Exclusion Criteria:
- IVF cycle with PGT for monogenetic diseases
- cIVF cycles with PGT for aneuploidy without the intention to have an embryo transfer within 6 months
- Social freezing cycles
- Medical freezing cycles
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Antall grupper / kohorter
Kohorter og intervensjoner
Gruppe / KohortGruppe / Kohort |
|---|
|
Group 1
NC-/Min Stim IVF |
|
Group 2
cIVF |
|
Group 3/Mixed IVF Group
NC-/Min Stim IVF and cIVF |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Quality of life
Tidsramme: 6 months
|
Quality of life related to infertility will be analyzed using the Fertility Quality of Life (FertiQoL) questionnaire. The FertiQoL questionnaire contains 36 items in total, assessing the personal and interpersonal impact, quality of life specifically related to medical interventions, and general self-rated health and quality of life. Scores on the response scales are reversed, summed and scaled to range from 0 to 100. Higher scores on the subscales and total scores indicate better quality of life. |
6 months
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Mental Health
Tidsramme: 6 months
|
Mental health related to infertility will be analyzed using the Center for Epidemiologic Studies Depression Scale (CES-D) scale. The standard CES-D is a 20-item self-report questionnaire assessing depressive symptoms experienced over the past week. Scores range between 0 to 60. Higher scores indicate greater severity and frequency of depressive symptoms. |
6 months
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Factors first choice of IVF
Tidsramme: 6 months
|
Which factors have affected your first choice of IVF treatment strategy? |
6 months
|
|
Success rate
Tidsramme: 6 months
|
Number of pregnancies (clinical/ongoing), any live birth (defined as at least one delivery of a live infant resulting from all NC/Min stim-IVF, cIVF or mixed treatment cycles, inclusive frozen embryo transfer (FET) cycles until pregnancy occurred or until 6 months were over). Type of IVF (in each cycle): NC-, Min stim- and cIVF Number of miscarriages Number of ectopic pregnancies, others outcome of pregnancy Number of women who discontinue IVF treatment Premature ovulation: yes/no Number of oocytes, zygotes, embryos and frozen embryos (inclusive day of freezing) Preimplantation Genetic Testing (PGT) (yes or no) Technology of fertilization (IVF or ICSI or both) Day of embryo transfer (2, 3 or 5) Number of transferred embryos Number of frozen embryos remaining at the end of the six-month observation period (inclusive day of freezing) |
6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- PRO-IVF Study
- DLF-Nr: 6269 (Annen identifikator: Department für Lehre und Forschung)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .